vs
Side-by-side financial comparison of LAKELAND FINANCIAL CORP (LKFN) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.
LAKELAND FINANCIAL CORP is the larger business by last-quarter revenue ($69.7M vs $37.2M, roughly 1.9× Organogenesis Holdings Inc.). Over the past eight quarters, LAKELAND FINANCIAL CORP's revenue compounded faster (0.7% CAGR vs -46.5%).
Amscot Financial is an American financial services company headquartered in Tampa, Florida. Founded in 1989 by Ian MacKechnie, Amscot Financial provides non-bank consumer financial services through a network of retail branches located exclusively within Florida. Amscot's core services include check cashing, bill payment, prepaid access cards, payday loans, free money orders, ATMs in every branch, wire transfers, notary services, fax services, and postage. Amscot Financial operates nearly 240 ...
Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.
LKFN vs ORGO — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $69.7M | $37.2M |
| Net Profit | $26.5M | — |
| Gross Margin | — | 30.8% |
| Operating Margin | — | -185.1% |
| Net Margin | 38.0% | — |
| Revenue YoY | — | -57.1% |
| Net Profit YoY | 31.8% | — |
| EPS (diluted) | $1.04 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $69.7M | $37.2M | ||
| Q4 25 | $69.8M | $225.6M | ||
| Q3 25 | $69.0M | $150.9M | ||
| Q2 25 | $66.4M | $101.0M | ||
| Q1 25 | $63.8M | $86.7M | ||
| Q4 24 | $63.6M | $126.7M | ||
| Q3 24 | $61.2M | $115.2M | ||
| Q2 24 | $68.7M | $130.2M |
| Q1 26 | $26.5M | — | ||
| Q4 25 | $29.9M | $43.7M | ||
| Q3 25 | $26.4M | $21.6M | ||
| Q2 25 | $27.0M | $-9.4M | ||
| Q1 25 | $20.1M | $-18.8M | ||
| Q4 24 | $24.2M | $7.7M | ||
| Q3 24 | $23.3M | $12.3M | ||
| Q2 24 | $22.5M | $-17.0M |
| Q1 26 | — | 30.8% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 72.6% | ||
| Q4 24 | — | 75.5% | ||
| Q3 24 | — | 76.7% | ||
| Q2 24 | — | 77.6% |
| Q1 26 | — | -185.1% | ||
| Q4 25 | 52.1% | 28.1% | ||
| Q3 25 | 46.4% | 13.7% | ||
| Q2 25 | 49.6% | -12.5% | ||
| Q1 25 | 38.0% | -30.9% | ||
| Q4 24 | 46.0% | 8.1% | ||
| Q3 24 | 45.3% | 5.4% | ||
| Q2 24 | 39.2% | -10.7% |
| Q1 26 | 38.0% | — | ||
| Q4 25 | 42.8% | 19.4% | ||
| Q3 25 | 38.3% | 14.3% | ||
| Q2 25 | 40.6% | -9.3% | ||
| Q1 25 | 31.5% | -21.7% | ||
| Q4 24 | 38.1% | 6.1% | ||
| Q3 24 | 38.1% | 10.7% | ||
| Q2 24 | 32.8% | -13.1% |
| Q1 26 | $1.04 | — | ||
| Q4 25 | $1.16 | $0.31 | ||
| Q3 25 | $1.03 | $0.11 | ||
| Q2 25 | $1.04 | $-0.10 | ||
| Q1 25 | $0.78 | $-0.17 | ||
| Q4 24 | $0.94 | $0.05 | ||
| Q3 24 | $0.91 | $0.09 | ||
| Q2 24 | $0.87 | $-0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $85.6M | $91.4M |
| Total DebtLower is stronger | $183.6M | — |
| Stockholders' EquityBook value | $749.0M | — |
| Total Assets | $7.1B | $520.0M |
| Debt / EquityLower = less leverage | 0.25× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $85.6M | $91.4M | ||
| Q4 25 | $141.3M | $93.7M | ||
| Q3 25 | $192.8M | $63.7M | ||
| Q2 25 | $310.2M | $73.1M | ||
| Q1 25 | $235.2M | $110.0M | ||
| Q4 24 | $168.2M | $135.6M | ||
| Q3 24 | $160.2M | $94.3M | ||
| Q2 24 | $121.2M | $89.9M |
| Q1 26 | $183.6M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $30.0M | $62.3M | ||
| Q2 24 | $55.0M | $63.8M |
| Q1 26 | $749.0M | — | ||
| Q4 25 | $762.4M | $300.1M | ||
| Q3 25 | $747.4M | $255.1M | ||
| Q2 25 | $709.9M | $233.2M | ||
| Q1 25 | $694.4M | $242.9M | ||
| Q4 24 | $683.8M | $262.9M | ||
| Q3 24 | $699.1M | $278.5M | ||
| Q2 24 | $654.5M | $263.5M |
| Q1 26 | $7.1B | $520.0M | ||
| Q4 25 | $7.0B | $598.7M | ||
| Q3 25 | $6.9B | $509.8M | ||
| Q2 25 | $7.0B | $461.1M | ||
| Q1 25 | $6.9B | $467.4M | ||
| Q4 24 | $6.7B | $497.9M | ||
| Q3 24 | $6.6B | $446.3M | ||
| Q2 24 | $6.6B | $443.2M |
| Q1 26 | 0.25× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.04× | 0.22× | ||
| Q2 24 | 0.08× | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LKFN
| Net Interest Income | $56.8M | 81% |
| Noninterest Income | $12.9M | 19% |
ORGO
Segment breakdown not available.
